Novel therapeutic targets in neurodegenerative diseases: Lessons from amyotrophic lateral sclerosis Stanley H. AppelDavid R. BeersWeihua Zhao Invited Commentary 16 October 2008 Pages: 353 - 355
Donepezil in patients with subcortical vascular cognitive impairment Karen Marder Clinical Trials Report 16 October 2008 Pages: 361 - 362
Understanding hippocampal sclerosis in the elderly: Epidemiology, characterization, and diagnostic issues Chris ZarowTraci E. SitzerHelena C. Chui OriginalPaper 16 October 2008 Pages: 363 - 370
Normal pressure hydrocephalus: Diagnosis and treatment David ShprecherJason SchwalbRoger Kurlan OriginalPaper 16 October 2008 Pages: 371 - 376
Driving and neurodegenerative diseases Ergun Y. UcMatthew Rizzo OriginalPaper 16 October 2008 Pages: 377 - 383
The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer’s disease Joseph H. LeeSandra BarralChristiane Reitz OriginalPaper 16 October 2008 Pages: 384 - 391
The syndrome of optic nerve hypoplasia Mark BorchertPamela Garcia-Filion OriginalPaper 16 October 2008 Pages: 395 - 403
Drusen of the optic disc Byron L. LamChristopher G. Morais JrJoshua Pasol OriginalPaper 16 October 2008 Pages: 404 - 408
Cavitary anomalies of the optic disc: Neurologic significance Karl C. Golnik OriginalPaper 16 October 2008 Pages: 409 - 413
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis Dennis BourdetteVijayshree Yadav Clinical Trials Report 16 October 2008 Pages: 417 - 418
Monoclonal antibody treatments for multiple sclerosis John W. RoseJohn FoleyNoel Carlson OriginalPaper 16 October 2008 Pages: 419 - 426
Neuromyelitis optica: Diagnosis, pathogenesis, and treatment Bruce Cree OriginalPaper 16 October 2008 Pages: 427 - 433
Pediatric multiple sclerosis Dorothee ChabasJonathan StroberEmmanuelle Waubant OriginalPaper 16 October 2008 Pages: 434 - 441